UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Update on HIV/HCV Coinfection

Current HIV/AIDS reports, 2013-09, Vol.10 (3), p.226-234

2013

Link zum Volltext

Verfügbarkeit prüfen

Noncirrhotic portal hypertension in HIV infection

Current opinion in infectious diseases, 2011-02, Vol.24 (1), p.12-18

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B in HIV-Infected Patients

Clinics in liver disease, 2013-08, Vol.17 (3), p.489-501

2013

Link zum Volltext

Verfügbarkeit prüfen

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C

Antiviral therapy, 2013-01, Vol.18 (8), p.1033-1035

2013

Link zum Volltext

Verfügbarkeit prüfen

Viral hepatitis and HIV co-infection

Antiviral research, 2010, Vol.85 (1), p.303-315

2010

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Hepatitis C in Patients Infected with Human Immunodeficiency Virus in the Direct-Acting Antiviral Era

Infectious disease clinics of North America, 2012-12, Vol.26 (4), p.931-948

2012

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral-associated portal hypertension : a new clinical condition? Prevalence, predictors and outcome

Antiviral therapy, 2008, Vol.13 (1), p.103-107

2008

Link zum Volltext

Verfügbarkeit prüfen

Directly acting antivirals against hepatitis C virus

Journal of antimicrobial chemotherapy, 2011-08, Vol.66 (8), p.1673-1686

2011

Link zum Volltext

Verfügbarkeit prüfen

Management and treatment of chronic hepatitis C in HIV patients

Seminars in liver disease, 2012-05, Vol.32 (2), p.138

2012

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption

Retrovirology, 2010-05, Vol.7 (S1), p.O13-O13, Article O13

2010

Link zum Volltext

Verfügbarkeit prüfen

Glomerular filtration (GF) determined by creatinine clearance (CCR) in 24 hours urine and cockcroft & gault (cg) and modification of diet in renal disease (MDRD) equations in a large cohort of HIV+ patients

Retrovirology, 2010-05, Vol.7 (S1), p.P76-P76, Article P76

2010

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of new oral hepatitis C antiviral drugs

Expert opinion on drug metabolism & toxicology, 2013-01, Vol.9 (1), p.5-16

2013

Link zum Volltext

Verfügbarkeit prüfen

Treatment failure with new hepatitis C drugs

Expert opinion on pharmacotherapy, 2012-02, Vol.13 (3), p.313-323

2012

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C therapy with HCV NS5B polymerase inhibitors

Expert opinion on pharmacotherapy, 2013-06, Vol.14 (9), p.1161-1170

2013

Link zum Volltext

Verfügbarkeit prüfen

Management of hepatitis B virus co-infection on and off antiretroviral therapy

Current HIV/AIDS reports, 2008-05, Vol.5 (2), p.86-93

2008

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics of hepatitis C

Journal of antimicrobial chemotherapy, 2012-03, Vol.67 (3), p.523-529

2012

Link zum Volltext

Verfügbarkeit prüfen

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

Liver international, 2013-10, Vol.33 (9), p.1357-1362

2013

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor

Antiviral therapy, 2012-01, Vol.17 (5), p.921-926

2012

Link zum Volltext

Verfügbarkeit prüfen

Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV

Journal of antimicrobial chemotherapy, 2012-05, Vol.67 (5), p.1246-1249

2012

Link zum Volltext

Verfügbarkeit prüfen

Emerging antiretroviral drugs

Expert opinion on pharmacotherapy, 2014-02, Vol.15 (2), p.211-219

2014

Link zum Volltext

Verfügbarkeit prüfen

Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C

Journal of antimicrobial chemotherapy, 2010-03, Vol.65 (3), p.543-547

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial

Journal of antimicrobial chemotherapy, 2008-01, Vol.61 (1), p.200-205

2008

Link zum Volltext

Verfügbarkeit prüfen

Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome

Journal of antimicrobial chemotherapy, 2008-03, Vol.61 (3), p.699-704

2008

Link zum Volltext

Verfügbarkeit prüfen

The changing face of hepatitis C in the new era of direct-acting antivirals

Antiviral research, 2013-01, Vol.97 (1), p.36-40

2013

Link zum Volltext

Verfügbarkeit prüfen

Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b

Journal of clinical virology, 2012-09, Vol.55 (1), p.58-61

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 66

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(64)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Update on HIV/HCV Coinfection

Noncirrhotic portal hypertension in HIV infection

Hepatitis B in HIV-Infected Patients

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C

Viral hepatitis and HIV co-infection

Treatment of Hepatitis C in Patients Infected with Human Immunodeficiency Virus in the Direct-Acting Antiviral Era

Antiretroviral-associated portal hypertension : a new clinical condition? Prevalence, predictors and outcome

Directly acting antivirals against hepatitis C virus

Management and treatment of chronic hepatitis C in HIV patients

Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption

Glomerular filtration (GF) determined by creatinine clearance (CCR) in 24 hours urine and cockcroft & gault (cg) and modification of diet in renal disease (MDRD) equations in a large cohort of HIV+ patients

Pharmacokinetics of new oral hepatitis C antiviral drugs

Treatment failure with new hepatitis C drugs

Hepatitis C therapy with HCV NS5B polymerase inhibitors

Management of hepatitis B virus co-infection on and off antiretroviral therapy

Pharmacogenetics of hepatitis C

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor

Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV

Emerging antiretroviral drugs

Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C

Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial

Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome

The changing face of hepatitis C in the new era of direct-acting antivirals

Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b

Aktive Filter

Suchergebnisse filtern